Market Overview:

The global Peripheral Vascular Devices Market is experiencing rapid growth, driven by Growing Initiatives to Achieve Net-Zero Carbon Emissions, Technological Advancements in Electrolysis and Increasing Private Sector Investments and Government Support. According to IMARC Group's latest research publication, “Peripheral Vascular Devices Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033”, The global peripheral vascular devices market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Peripheral Vascular Devices Industry:

• Increasing Prevalence of Peripheral Vascular Diseases 

Chronic Total Occlusions or arteries completely blocked pose difficulties for treatment. Devices and techniques are being introduced for the treatment of CTOs percutaneously by interventional cardiologists in a minimally intrusive fashion at this time. The introduction of novel CTO devices such as recanalization and re-entry systems can penetrate and cross these highly tortuous patterns of disease, offering an alternative to open surgery. As the success of percutaneous procedures improves, the population with less complex lesions eligible for percutaneous procedures will expand. In tandem, the medical specialty is evolving in terms of the number of physicians with specialized training and the credentialing of more difficult cases, along with an increase in the number of advanced CTO devices and techniques offered to provide patients with better clinical outcomes who have few alternatives.

• Technological Advancements

Peripheral vascular surgery gains precision and effectiveness from imaging systems and robotic-assisted devices. Intravascular Ultrasound (IVUS) systems and Optical Coherence Tomography (OCT) systems provide cross-sectional visualizations of blood vessels at high resolution in real-time. This provides information of the type of plaque in the artery and the exact position for the balloon or stent. Robotic-assisted surgical systems, which were introduced for improvement of maneuverability, stability, and control during complex procedures, and robotic imaging systems, which were integrated for ease of interventional procedures, are helping to improve procedural outcomes, minimize radiation exposure to the physician and patient, and provide additional safety and precision. This is expected to become more common from now on, as technology becomes more affordable and providers seek to standardize and improve complex procedures.

• Favorable Regulatory and Reimbursement Landscape

One strong trend is the evolution of bare-metal stents (BMS) towards advanced concepts such as drug-coated balloons (DCB). A DCB delivers an anti-proliferative drug to the arterial wall to lower the risk of re-narrowing without the need for an implant. This is particularly useful in cases of small-vessel disease or in cases where stent placement for long periods of time is inappropriate. Bioresorbable scaffolds are also used for temporary support of the vessel and are thought, by virtue of their resorbability, to allow for a return to normal arterial function. Despite some hurdles, these technologies have been touted as the future of vascular intervention because they intervene in chronic inflammation and thrombosis from permanent implants, such as stents and grafts.

Key Trends in the Peripheral Vascular Devices Market:

• Development and Adoption

One of the most significant trends is the shift from traditional bare-metal stents to more advanced technologies like drug-coated balloons (DCBs) and bioresorbable scaffolds. DCBs deliver an anti-proliferative drug directly to the arterial wall, preventing re-narrowing without leaving a permanent implant behind. This is particularly beneficial for small-vessel disease or in cases where long-term stent placement is not ideal. Similarly, bioresorbable scaffolds are designed to provide temporary support to the vessel and then dissolve naturally over time, allowing the artery to regain its natural function. Although still facing some challenges, these technologies are seen as the future of vascular intervention, as they address the long-term issues associated with permanent implants, such as chronic inflammation and thrombosis.

• Integration of Advanced Imaging and Robotic-Assisted Surgery

The precision and success of peripheral vascular procedures are being enhanced by the integration of advanced imaging systems and robotic-assisted technologies. Devices such as Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) provide high-resolution, real-time images of the inside of blood vessels, allowing physicians to precisely assess plaque composition and accurately place stents or balloons. In parallel, robotic-assisted systems are being developed to provide surgeons with enhanced dexterity, stability, and control during complex interventions. This fusion of imaging and robotics is leading to improved procedural outcomes, reduced radiation exposure for both the patient and the physician, and a higher level of safety and precision. This trend is expected to grow as technology becomes more accessible and healthcare providers seek to standardize and optimize complex procedures.

• Focus on Minimally Invasive Solutions for Chronic Total Occlusions 

The treatment of Chronic Total Occlusions (CTOs)—completely blocked arteries—has historically been challenging. However, a key trend is the development of specialized devices and techniques to address these complex lesions using a minimally invasive approach. New CTO devices, including recanalization and re-entry systems, are designed to navigate and open these difficult blockages, offering a viable alternative to open surgery. This focus on improving the success rate of percutaneous procedures for CTOs is broadening the patient population eligible for less-invasive interventions. The industry is also seeing a rise in specialized training and certification for physicians to handle these complex cases, further driving the adoption of advanced CTO devices and techniques. This trend is driven by the demand for better clinical outcomes in patients who previously had limited treatment options.

The peripheral vascular devices market forecast offers insights into future opportunities and challenges, drawing on historical data and predictive modeling.

Leading Companies Operating in the Global Peripheral Vascular Devices Industry:

• Abbott Laboratories
• B. Braun SE
• Boston Scientific Corporation
• Cordis
• iVascular S.L.U.
• Medtronic plc
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• W. L. Gore & Associates, Inc.

Peripheral Vascular Devices Market Report Segmentation:

Breakup by Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others  

Peripheral vascular stents dominate the market, followed by PTA balloon catheters, PTA guidewires, atherectomy devices, embolic protection devices, inferior vena cava filters, and others.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others  

Hospitals and clinics hold the largest market share, with ambulatory care centers, specialty clinics, and others following.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

America leads the market, with significant contributions from Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302